Population Group – Page 4

BioSpace Presents the World Atlas of GLP-1s

9 months ago talkbio0Tagged BioSpace, Brazil, Cervical Atlas, China, Eli Lilly, GLP-1s, Glucagon-Like Peptide 1, India, Nordisk, Wegovy, World

Eli Lilly, Wegovy, India, China, BioSpace, World, Cervical Atlas, GLP-1s, Nordisk, Glucagon-Like Peptide 1, Brazil, India

Dexcom survey shows healthcare providers opt for CGM tech over new medications in Type 2 diabetes

9 months ago talkbio0Tagged CGM, Continuous Glucose Monitoring System, Diabetes Mellitus, Non-Insulin-Dependent, Health Personnel, Technology

Continuous Glucose Monitoring System, Technology, Health Personnel, CGM, Diabetes Mellitus, Non-Insulin-Dependent

Servier Acquires Rights to Black Diamond’s Solid Tumor Drug BDTX-4933 in $780M Deal

9 months ago talkbio0Tagged BDTX-4933, Black Populations, Diamond Therapeutics, licensing agreement, RAS/RAF inhibitor, Servier, Solid Neoplasm

Servier, Black Diamond Therapeutics, BDTX-4933, solid tumors, licensing agreement, RAS/RAF inhibitor

Indian Biomanufacturing Alliance: Boosting National Capabilities

10 months ago talkbio0Tagged Asian Indian, biomanufacturing, Collaboration, drugmakers, national sector growth, TNFRSF19 gene

Indian drugmakers, biomanufacturing, trade group, collaboration, national sector growth

Gilead’s Seladelpar Receives Conditional EU Approval for Primary Biliary Cholangitis Treatment

10 months ago talkbio0Tagged Biliary Cholangitis, Commission, Conditional, European (ethnic group), Gilead Sciences, Primary Biliary Cholangitis, Response process, seladelpar, ursodiol

Seladelpar, Gilead Sciences, primary biliary cholangitis, PBC, European Commission, conditional marketing authorization, RESPONSE trial, ursodeoxycholic acid (UDCA)

Pfizer’s European Manufacturing Vulnerable to Potential US Tariffs, CEO Warns

10 months ago talkbio0Tagged Albert, Bourla, chain disruption, Drug Industry, European (ethnic group), Manufacturing, Pfizer, Tension, TNFRSF19 gene, U.S.

Pfizer, Albert Bourla, European manufacturing, US tariffs, pharmaceutical industry, trade tensions, supply chain disruption

Bavarian Nordic’s Vimkunya Approved by FDA as First Chikungunya Vaccine for Ages 12 and Up

10 months ago talkbio0Tagged Adolescent (age group), Approved, Bavarian Nordic, chikungunya vaccine, traveler, United States Food and Drug Administration, Vaccines, Virus-Like Particle, Vimkunya

Vimkunya, chikungunya vaccine, Bavarian Nordic, FDA approval, virus-like particle vaccine, adolescents, travelers

Galderma’s Nemluvio Secures Dual EU Approvals for Atopic Dermatitis and Prurigo Nodularis

10 months ago talkbio0Tagged Commission approval, Dermatitis, Atopic, European (ethnic group), Galderma, IL-31 receptor alpha, Monoclonal Antibodies, Nemluvio, nemolizumab, nodularis, Prurigo

Nemluvio, nemolizumab, Galderma, European Commission approval, atopic dermatitis, prurigo nodularis, IL-31 receptor alpha, monoclonal antibody

ViiV Healthcare’s Multifaceted Approach to Combating HIV in Black Communities

10 months ago talkbio0Tagged Black Populations, care activity, Community, community grants, HIV Prevention, Indication of (contextual qualifier), Risk, Social stigmata, ViiV Healthcare

ViiV Healthcare, HIV prevention, Black communities, Risk to Reasons, community grants, stigma reduction, education, access to care

NFL Legend Jerome Bettis Joins CDC Foundation’s “Live to the Beat” Campaign to Tackle Heart Health in Black Community

10 months ago talkbio0Tagged beat, Bettis, Black Populations, Cardiovascular Diseases, Centers for Disease Control and Prevention (U.S.), Community, Foundations, heart health, Hypertensive disease, Jerome, NEFL gene

Jerome Bettis, CDC Foundation, Live to the Beat, cardiovascular disease, Black community, hypertension, heart health, NFL